Gleostine is an alkylating drug indicated
    for the treatment of patients with:

  • Brain tumors, primary and metastatic,
    following appropriate surgical
    and/or radiotherapeutic procedures.

  • Hodgkin’s lymphoma in combination
    with other chemotherapies, following
    disease progression with initial chemotherapy.

PATIENT ASSISTANCE PROGRAM

Azurity Pharmaceuticals provides Gleostine® (lomustine) capsules to patients for whom a medical need is established.

LEARN MORE